Perceptive Advisors as of March 31, 2025
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 86 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Verona Pharma Sponsored Ads (VRNA) | 14.7 | $417M | 6.6M | 63.49 | |
| Arcellx Common Stock (ACLX) | 6.8 | $192M | 2.9M | 65.60 | |
| Amicus Therapeutics (FOLD) | 6.2 | $175M | 22M | 8.16 | |
| Edgewise Therapeutics (EWTX) | 5.5 | $155M | 7.0M | 22.00 | |
| Rhythm Pharmaceuticals (RYTM) | 4.8 | $135M | 2.5M | 52.97 | |
| Nuvalent Inc-a (NUVL) | 4.1 | $116M | 1.6M | 70.92 | |
| Soleno Therapeutics (SLNO) | 3.8 | $108M | 1.5M | 71.45 | |
| Intra Cellular Therapies (ITCI) | 3.7 | $104M | 786k | 131.92 | |
| Meiragtx Holdings (MGTX) | 3.0 | $85M | 13M | 6.78 | |
| CryoLife (AORT) | 2.4 | $69M | 2.8M | 24.58 | |
| Aldeyra Therapeutics (ALDX) | 1.9 | $53M | 9.3M | 5.75 | |
| Protagonist Therapeutics (PTGX) | 1.9 | $53M | 1.1M | 48.36 | |
| Evolus (EOLS) | 1.8 | $50M | 4.1M | 12.03 | |
| Immunovant (IMVT) | 1.7 | $49M | 2.8M | 17.09 | |
| Solid Biosciences Com New (SLDB) | 1.6 | $44M | 12M | 3.70 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.5 | $44M | 3.0M | 14.38 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $42M | 13M | 3.33 | |
| Immatics SHS (IMTX) | 1.5 | $42M | 9.4M | 4.51 | |
| Apogee Therapeutics (APGE) | 1.5 | $42M | 1.1M | 37.36 | |
| Axsome Therapeutics (AXSM) | 1.5 | $41M | 355k | 116.63 | |
| Insmed Com Par $.01 (INSM) | 1.4 | $39M | 509k | 76.29 | |
| Spyre Therapeutics Com New (SYRE) | 1.3 | $37M | 2.3M | 16.14 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.3 | $37M | 981k | 37.87 | |
| Argenx Se Sponsored Adr (ARGX) | 1.2 | $35M | 60k | 591.87 | |
| Astria Therapeutics (ATXS) | 1.2 | $35M | 6.5M | 5.34 | |
| Akero Therapeutics (AKRO) | 1.1 | $32M | 793k | 40.48 | |
| Merus N V (MRUS) | 1.0 | $29M | 691k | 42.09 | |
| Amylyx Pharmaceuticals (AMLX) | 1.0 | $28M | 7.9M | 3.54 | |
| Adma Biologics (ADMA) | 1.0 | $27M | 1.4M | 19.84 | |
| Beta Bionics (BBNX) | 1.0 | $27M | 2.2M | 12.24 | |
| Vaxcyte (PCVX) | 0.9 | $27M | 707k | 37.76 | |
| Janux Therapeutics (JANX) | 0.9 | $26M | 970k | 27.00 | |
| Dyne Therapeutics (DYN) | 0.9 | $24M | 2.3M | 10.46 | |
| Celcuity (CELC) | 0.8 | $24M | 2.4M | 10.11 | |
| Zymeworks Del (ZYME) | 0.8 | $22M | 1.9M | 11.91 | |
| Intuitive Surgical Com New (ISRG) | 0.7 | $20M | 41k | 495.27 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.7 | $20M | 4.6M | 4.28 | |
| Insulet Corporation (PODD) | 0.7 | $19M | 72k | 262.61 | |
| Repligen Corporation (RGEN) | 0.6 | $17M | 130k | 127.24 | |
| Bright Minds Biosciences Com New (DRUG) | 0.6 | $16M | 445k | 36.07 | |
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $15M | 47k | 331.23 | |
| Inhibrx Biosciences (INBX) | 0.5 | $15M | 1.1M | 13.99 | |
| Boston Scientific Corporation (BSX) | 0.5 | $13M | 130k | 100.88 | |
| Sionna Therapeutics (SION) | 0.5 | $13M | 1.3M | 10.46 | |
| Inhibikase Therapeutics Com New (IKT) | 0.5 | $13M | 5.9M | 2.19 | |
| Viking Therapeutics (VKTX) | 0.4 | $12M | 509k | 24.15 | |
| Dex (DXCM) | 0.4 | $12M | 178k | 68.29 | |
| Neurocrine Biosciences (NBIX) | 0.4 | $11M | 100k | 110.60 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $11M | 325k | 33.55 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.4 | $11M | 5.4M | 2.03 | |
| Nautilus Biotechnology (NAUT) | 0.4 | $11M | 13M | 0.86 | |
| Aquestive Therapeutics (AQST) | 0.4 | $11M | 3.7M | 2.90 | |
| Contineum Therapeutics Cl A (CTNM) | 0.4 | $10M | 1.4M | 6.98 | |
| Cargo Therapeutics (CRGX) | 0.3 | $9.9M | 2.4M | 4.07 | |
| Outset Med Com New (OM) | 0.3 | $9.2M | 833k | 11.06 | |
| Miragen Therapeutics (VRDN) | 0.3 | $8.9M | 660k | 13.48 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.3 | $8.3M | 1.5M | 5.42 | |
| Adagio Med Hldgs (ADGM) | 0.3 | $7.9M | 9.8M | 0.81 | |
| Anteris Technologies Global (AVR) | 0.3 | $7.8M | 2.1M | 3.64 | |
| Disc Medicine (IRON) | 0.3 | $7.4M | 150k | 49.64 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $6.9M | 931k | 7.43 | |
| Ocular Therapeutix (OCUL) | 0.2 | $6.7M | 916k | 7.33 | |
| Delcath Sys Com New (DCTH) | 0.2 | $5.9M | 462k | 12.73 | |
| Rapt Therapeutics | 0.2 | $5.4M | 4.4M | 1.22 | |
| Kestra Med Technologies SHS (KMTS) | 0.2 | $5.0M | 200k | 24.92 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.2 | $4.5M | 398k | 11.30 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.2 | $4.3M | 1.0M | 4.30 | |
| Ocuphire Pharma (IRD) | 0.1 | $4.2M | 4.3M | 0.98 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $4.2M | 520k | 8.01 | |
| Nurix Therapeutics (NRIX) | 0.1 | $3.5M | 298k | 11.88 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $2.0M | 877k | 2.25 | |
| Lyra Therapeutics | 0.1 | $1.6M | 13M | 0.13 | |
| Kala Bio Com New (KALA) | 0.1 | $1.6M | 278k | 5.73 | |
| Athira Pharma (ATHA) | 0.1 | $1.5M | 5.4M | 0.28 | |
| Biodesix (BDSX) | 0.0 | $1.4M | 2.2M | 0.62 | |
| Scpharmaceuticals (SCPH) | 0.0 | $1.3M | 500k | 2.63 | |
| Traws Pharma Com New (TRAW) | 0.0 | $970k | 422k | 2.30 | |
| Rocket Pharmaceuticals (RCKT) | 0.0 | $939k | 141k | 6.67 | |
| Cullinan Oncology (CGEM) | 0.0 | $606k | 80k | 7.57 | |
| Lexeo Therapeutics (LXEO) | 0.0 | $485k | 140k | 3.47 | |
| Applied Therapeutics (APLT) | 0.0 | $421k | 860k | 0.49 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.0 | $376k | 105k | 3.58 | |
| Ensysce Biosciences Com New (ENSC) | 0.0 | $222k | 87k | 2.56 | |
| Apyx Medical Corporation (APYX) | 0.0 | $206k | 150k | 1.37 | |
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $9.5k | 250k | 0.04 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $5.0k | 167k | 0.03 |
